No CrossRef data available.
Article contents
Tratamiento del trastorno por déficit de atención con hiperactividad (tipo residual) con moclobemida
Published online by Cambridge University Press: 12 May 2020
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Cartas al editor
- Information
- Copyright
- Copyright © European Psychiatric Association 1995
References
Bibliografía
Parquet, PJ, Servant, D, Servant, DBailly, Det al. Monoamine oxidase inhibitor in the treatment of attention déficit disorder of residual type. A propos of a case. Encephale 1988; Nov-Dec, 14/6: 439–41.Google Scholar
Wenker, PH, Garfinkel, BD. Attention Deficit Hyperactivity Disorder: Adult Manifestations. In: Kaplan, HI, Sadock, BJ, eds. Comprehensivo Textbook Of Psychiatry, vol 2, 5th ed. Baltimore: Williams and Wilkins, 1989; 1837–41.Google Scholar
Biederman, J, Newcorn, J, Spnah, S. Comorbidity of Attention Deficit Hyperactivity Disorder with conduct, depressive, anxiety and other disorders. Am J Psychiatry 1991; 148/5: 564–77.Google ScholarPubMed
Shakim, WO, Asarnow, RF, Hess, Eet al. A clinical and demographic profile of a sample of adults with attention déficit hyperactivity disorder, residual state. Compr Psychiatry 1990; 31/5: 416–25.CrossRefGoogle Scholar
Trott, GE, Friese, HJ, Menzel, Met alUse of Moclobemide in children with attention deficit hyperactivity disorder. Psychophannacologv 1992; 106: SI 34–6.Google ScholarPubMed
You have
Access